Confronting An Epidemic of Heart Failure

COVID-19 highlights the acute need for non-invasive, point-of-care, remote monitoring

hemodynamic measurement solutions. Find out how CPS meets the need.

about the COMPANY 

Sensydia is committed to developing technology for the rapid, non-invasive diagnosis and management of patients with heart disease. Sensydia merged expertise in clinical cardiology, biomedical engineering and machine learning in the development of fast, wireless cardiac function monitoring. The CPS system is enabled by advances in machine learning coupled with pre-clinical research, clinical trials and years of experience in cardiac critical care. Sensydia’s mission is to provide fast, easy-to-use, non-invasive monitoring of key cardiac performance metrics to reduce readmissions, lower the cost of care and improve outcomes for patients with heart disease

EXPERIENCED TEAM

The Sensydia team recognized a major unmet need and opportunity to improve management and diagnosis of patients with heart failure and other critical care issues. We are committed to reducing the cost of care for these patients, reducing readmissions and ultimately improving outcomes and quality of life.

 

The Sensydia team merges expertise in clinical cardiology, biomedical engineering and machine learning in the development of fast, wireless cardiac function monitoring, with a mission to provide fast, easy-to-use, non-invasive monitoring of key cardiac performance metrics.

Anthony Arnold

CEO

Anthony has over 25 years experience in the development of successful, high-tech medical devices. Anthony was the CEO and a board member for SetPoint Medical where he grew the company from a three-person start-up to the leading clinical-stage bioelectronic medicine company. Prior to SetPoint he served as VP of Marketing for Boston Scientific and was Director of Marketing at Medtronic. Anthony serves as advisor and board member for numerous early-stage device companies.

Dr. Aman Mahajan

MD, Ph.D, MBA, CMO 

Dr. Mahajan (MD PhD MBA) serves as Department Chair and Director of Perioperative Services, University of Pittsburgh Physicians/UPMC. He is Professor of Department of Anesthesiology and Bioinformatics. Dr. Mahajan also holds the endowed Peter and Eva Safar Professorship at UPMC.

WiLliam Kaiser

CTO

William J. Kaiser Ph.D. is Distinguished Professor of Electrical and Computer Engineering at UCLA.  His background includes product development focused on advancing patient outcomes, promoting health and wellness and creating new healthcare delivery methods.

William A. Hawkins

ADVISOR

William is Former Chairman and CEO of Medtronic. He is Senior Advisor to EW Healthcare Partners, Vice Chair of Duke Board of Trustees and Chairman of Duke University Health System. He is also an NAE Member.

1100 Glendon Ave., Suite 1715

Los Angeles, CA 90024

info@sensydia.com

 

 

 

 

 


 

© 2020 Sensydia

  • LinkedIn